An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays

Abstract A novel coronavirus of zoonotic origin (SARS-CoV-2) has recently been recognized in patients with acute respiratory disease. COVID-19 causative agent is structurally and genetically similar to SARS and bat SARS-like coronaviruses. The drastic increase in the number of coronavirus and its ge...

Full description

Bibliographic Details
Main Authors: Yasin Orooji, Hessamaddin Sohrabi, Nima Hemmat, Fatemeh Oroojalian, Behzad Baradaran, Ahad Mokhtarzadeh, Mohamad Mohaghegh, Hassan Karimi-Maleh
Format: Article
Language:English
Published: SpringerOpen 2020-11-01
Series:Nano-Micro Letters
Subjects:
Online Access:http://link.springer.com/article/10.1007/s40820-020-00533-y
id doaj-e025cfc79e1e44d996129e5e162f6c43
record_format Article
spelling doaj-e025cfc79e1e44d996129e5e162f6c432020-11-25T04:08:31ZengSpringerOpenNano-Micro Letters2311-67062150-55512020-11-0113113010.1007/s40820-020-00533-yAn Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical AssaysYasin Orooji0Hessamaddin Sohrabi1Nima Hemmat2Fatemeh Oroojalian3Behzad Baradaran4Ahad Mokhtarzadeh5Mohamad Mohaghegh6Hassan Karimi-Maleh7College of Materials Science and Engineering, Nanjing Forestry UniversityDepartment of Analytical Chemistry, Faculty of Chemistry, University of TabrizImmunology Research Center, Tabriz University of Medical SciencesDepartment of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical SciencesImmunology Research Center, Tabriz University of Medical SciencesImmunology Research Center, Tabriz University of Medical SciencesDepartment of Nanobiotechnology, School of Biological Sciences, Tarbiat Modares UniversityDepartment of Chemical Engineering, Laboratory of Nanotechnology, Quchan University of TechnologyAbstract A novel coronavirus of zoonotic origin (SARS-CoV-2) has recently been recognized in patients with acute respiratory disease. COVID-19 causative agent is structurally and genetically similar to SARS and bat SARS-like coronaviruses. The drastic increase in the number of coronavirus and its genome sequence have given us an unprecedented opportunity to perform bioinformatics and genomics analysis on this class of viruses. Clinical tests like PCR and ELISA for rapid detection of this virus are urgently needed for early identification of infected patients. However, these techniques are expensive and not readily available for point-of-care (POC) applications. Currently, lack of any rapid, available, and reliable POC detection method gives rise to the progression of COVID-19 as a horrible global problem. To solve the negative features of clinical investigation, we provide a brief introduction of the general features of coronaviruses and describe various amplification assays, sensing, biosensing, immunosensing, and aptasensing for the determination of various groups of coronaviruses applied as a template for the detection of SARS-CoV-2. All sensing and biosensing techniques developed for the determination of various classes of coronaviruses are useful to recognize the newly immerged coronavirus, i.e., SARS-CoV-2. Also, the introduction of sensing and biosensing methods sheds light on the way of designing a proper screening system to detect the virus at the early stage of infection to tranquilize the speed and vastity of spreading. Among other approaches investigated among molecular approaches and PCR or recognition of viral diseases, LAMP-based methods and LFAs are of great importance for their numerous benefits, which can be helpful to design a universal platform for detection of future emerging pathogenic viruses.http://link.springer.com/article/10.1007/s40820-020-00533-yELISAqRT-PCRSensing assayApta assayAmplification assay
collection DOAJ
language English
format Article
sources DOAJ
author Yasin Orooji
Hessamaddin Sohrabi
Nima Hemmat
Fatemeh Oroojalian
Behzad Baradaran
Ahad Mokhtarzadeh
Mohamad Mohaghegh
Hassan Karimi-Maleh
spellingShingle Yasin Orooji
Hessamaddin Sohrabi
Nima Hemmat
Fatemeh Oroojalian
Behzad Baradaran
Ahad Mokhtarzadeh
Mohamad Mohaghegh
Hassan Karimi-Maleh
An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays
Nano-Micro Letters
ELISA
qRT-PCR
Sensing assay
Apta assay
Amplification assay
author_facet Yasin Orooji
Hessamaddin Sohrabi
Nima Hemmat
Fatemeh Oroojalian
Behzad Baradaran
Ahad Mokhtarzadeh
Mohamad Mohaghegh
Hassan Karimi-Maleh
author_sort Yasin Orooji
title An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays
title_short An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays
title_full An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays
title_fullStr An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays
title_full_unstemmed An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays
title_sort overview on sars-cov-2 (covid-19) and other human coronaviruses and their detection capability via amplification assay, chemical sensing, biosensing, immunosensing, and clinical assays
publisher SpringerOpen
series Nano-Micro Letters
issn 2311-6706
2150-5551
publishDate 2020-11-01
description Abstract A novel coronavirus of zoonotic origin (SARS-CoV-2) has recently been recognized in patients with acute respiratory disease. COVID-19 causative agent is structurally and genetically similar to SARS and bat SARS-like coronaviruses. The drastic increase in the number of coronavirus and its genome sequence have given us an unprecedented opportunity to perform bioinformatics and genomics analysis on this class of viruses. Clinical tests like PCR and ELISA for rapid detection of this virus are urgently needed for early identification of infected patients. However, these techniques are expensive and not readily available for point-of-care (POC) applications. Currently, lack of any rapid, available, and reliable POC detection method gives rise to the progression of COVID-19 as a horrible global problem. To solve the negative features of clinical investigation, we provide a brief introduction of the general features of coronaviruses and describe various amplification assays, sensing, biosensing, immunosensing, and aptasensing for the determination of various groups of coronaviruses applied as a template for the detection of SARS-CoV-2. All sensing and biosensing techniques developed for the determination of various classes of coronaviruses are useful to recognize the newly immerged coronavirus, i.e., SARS-CoV-2. Also, the introduction of sensing and biosensing methods sheds light on the way of designing a proper screening system to detect the virus at the early stage of infection to tranquilize the speed and vastity of spreading. Among other approaches investigated among molecular approaches and PCR or recognition of viral diseases, LAMP-based methods and LFAs are of great importance for their numerous benefits, which can be helpful to design a universal platform for detection of future emerging pathogenic viruses.
topic ELISA
qRT-PCR
Sensing assay
Apta assay
Amplification assay
url http://link.springer.com/article/10.1007/s40820-020-00533-y
work_keys_str_mv AT yasinorooji anoverviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT hessamaddinsohrabi anoverviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT nimahemmat anoverviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT fatemehoroojalian anoverviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT behzadbaradaran anoverviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT ahadmokhtarzadeh anoverviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT mohamadmohaghegh anoverviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT hassankarimimaleh anoverviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT yasinorooji overviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT hessamaddinsohrabi overviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT nimahemmat overviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT fatemehoroojalian overviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT behzadbaradaran overviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT ahadmokhtarzadeh overviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT mohamadmohaghegh overviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
AT hassankarimimaleh overviewonsarscov2covid19andotherhumancoronavirusesandtheirdetectioncapabilityviaamplificationassaychemicalsensingbiosensingimmunosensingandclinicalassays
_version_ 1724425381635686400